Mohammed Gbadamosi

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Dna Damage Response

Clinical Decision Support

Acute Lymphoblastic Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Vivek M Shastri, Lata Chauhan, Mohammed Gbadamosi, Todd A Alonzo, Yi-Cheng Wang, Richard Aplenc, Betsy A Hirsch, Edward Anders Kolb, Alan S Gamis, Soheil Meshinchi, Jatinder Kaur Lamba
Genetic variation in DNA damage response pathway and response to Gemtuzumab Ozogamicin in pediatric AML: a report from the Children's Oncology Group. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Vivek M Shastri, Lata Chauhan, Mohammed Gbadamosi, Todd A Alonzo, Yi-Cheng Wang, Richard Aplenc, Betsy A Hirsch, Edward Anders Kolb, Alan S Gamis, Soheil Meshinchi, Jatinder Kaur Lamba
Genetic variation in DNA damage response pathway and response to Gemtuzumab Ozogamicin in pediatric AML: a report from the Children's Oncology Group. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Vivek M Shastri, Lata Chauhan, Mohammed Gbadamosi, Todd A Alonzo, Yi-Cheng Wang, Richard Aplenc, Betsy A Hirsch, Edward Anders Kolb, Alan S Gamis, Soheil Meshinchi, Jatinder Kaur Lamba
Genetic variation in DNA damage response pathway and response to Gemtuzumab Ozogamicin in pediatric AML: a report from the Children's Oncology Group. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Vivek M Shastri, Lata Chauhan, Mohammed Gbadamosi, Todd A Alonzo, Yi-Cheng Wang, Richard Aplenc, Betsy A Hirsch, Edward Anders Kolb, Alan S Gamis, Soheil Meshinchi, Jatinder Kaur Lamba
Genetic variation in DNA damage response pathway and response to Gemtuzumab Ozogamicin in pediatric AML: a report from the Children's Oncology Group. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Vivek M Shastri, Lata Chauhan, Mohammed Gbadamosi, Todd A Alonzo, Yi-Cheng Wang, Richard Aplenc, Betsy A Hirsch, Edward Anders Kolb, Alan S Gamis, Soheil Meshinchi, Jatinder Kaur Lamba
Genetic variation in DNA damage response pathway and response to Gemtuzumab Ozogamicin in pediatric AML: a report from the Children's Oncology Group. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Vivek M Shastri, Lata Chauhan, Mohammed Gbadamosi, Todd A Alonzo, Yi-Cheng Wang, Richard Aplenc, Betsy A Hirsch, Edward Anders Kolb, Alan S Gamis, Soheil Meshinchi, Jatinder Kaur Lamba
Genetic variation in DNA damage response pathway and response to Gemtuzumab Ozogamicin in pediatric AML: a report from the Children's Oncology Group. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)